Loading ticker data...
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2021-11-16 | Andrews Patricia S | Director | Buy | 40,000 | $2.05 | $82,000.00 | +761.9% | → |
| 2020-12-28 | King Rachel K. | President, CEO | Sale+OE | 84,176 | $3.91 | $329,128.16 | -19.1% | → |
| 2020-11-04 | BVF PARTNERS L P/IL | - | Buy | 1,266,737 | $2.60 | $3,293,516.20 | +15.7% | → |
| 2020-10-30 | BVF PARTNERS L P/IL | - | Buy | 932,612 | $2.75 | $2,564,683.00 | +13.1% | → |
| 2020-03-09 | JUNIUS DANIEL M | Director | Buy | 20,000 | $3.40 | $68,000.00 | +111.1% | → |
| 2019-09-05 | BVF PARTNERS L P/IL | - | Buy | 1,668,746 | $3.18 | $5,309,949.77 | +30.6% | → |
| 2019-08-13 | JUNIUS DANIEL M | Director | Buy | 10,000 | $3.18 | $31,800.00 | +125.0% | → |
| 2018-10-18 | Magnani John L. | SVP of Research, CSO | Sell | 25,000 | $14.01 | $350,212.54 | -9.4% | → |
| 2018-06-11 | Hahn Brian M. | CFO | Sale+OE | 19,345 | $18.04 | $348,983.80 | -100% | → |
| 2018-05-10 | SANDELL SCOTT D | 10% Owner | Sell | 9,539 | $17.81 | $169,889.59 | - | → |
| 2018-05-10 | NEW ENTERPRISE ASSOCIATES 10 L P | 10% Owner | Sell | 9,539 | $17.81 | $169,889.59 | - | → |
| 2018-05-10 | BARRETT M JAMES | Director, 10% Owner | Sell | 9,539 | $17.81 | $169,889.59 | - | → |
| 2018-05-10 | BARRIS PETER J | 10% Owner | Sell | 9,539 | $17.81 | $169,889.59 | - | → |
| 2017-12-08 | Thackray Helen M. | SVP Clinical Development, CMO | Sell | 2,000 | $15.01 | $30,020.00 | -1.3% | → |
| 2017-09-18 | Thackray Helen M. | SVP Clinical Development, CMO | Sell | 2,000 | $13.00 | $26,000.00 | -1.3% | → |
| 2017-05-25 | Thackray Helen M. | SVP Clinical Development, CMO | Sell | 2,000 | $15.57 | $31,140.00 | -1.3% | → |
| 2017-05-19 | Thackray Helen M. | SVP Clinical Development, CMO | Sell | 2,000 | $12.14 | $24,280.00 | -1.3% | → |
| 2016-12-20 | JUNIUS DANIEL M | Director | Buy | 5,000 | $6.01 | $30,050.00 | New | → |
| 2016-10-03 | Thackray Helen M. | VP Clinical Development, CMO | Sell | 4,000 | $7.00 | $28,001.00 | -1.3% | → |
| 2016-07-20 | Thackray Helen M. | VP Clinical Development, CMO | Sell | 2,000 | $8.00 | $16,000.00 | -1.2% | → |
| 2016-07-06 | Thackray Helen M. | VP Clinical Development, CMO | Sell | 22,000 | $7.00 | $153,953.84 | -4.1% | → |
| 2016-03-04 | Goldberg Mark Alan | Director | Buy | 10,397 | $4.77 | $49,630.08 | +945.2% | → |
| 2015-11-16 | SANDELL SCOTT D | 10% Owner | Sell | 452 | $6.91 | $3,123.32 | - | → |
| 2015-11-16 | BARRIS PETER J | 10% Owner | Sell | 452 | $6.91 | $3,123.32 | - | → |
| 2015-11-16 | BARRETT M JAMES | Director, 10% Owner | Sell | 452 | $6.91 | $3,123.32 | - | → |
| 2015-11-16 | NEW ENTERPRISE ASSOCIATES 10 L P | 10% Owner | Sell | 452 | $6.91 | $3,123.32 | - | → |